Does OBINUTUZUMAB Cause Chronic obstructive pulmonary disease? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Chronic obstructive pulmonary disease have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.2% of all adverse event reports for OBINUTUZUMAB.
25
Reports of Chronic obstructive pulmonary disease with OBINUTUZUMAB
0.2%
of all OBINUTUZUMAB reports
5
Deaths
15
Hospitalizations
How Dangerous Is Chronic obstructive pulmonary disease From OBINUTUZUMAB?
Of the 25 reports, 5 (20.0%) resulted in death, 15 (60.0%) required hospitalization.
Is Chronic obstructive pulmonary disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Chronic obstructive pulmonary disease?
ALBUTEROL (2,916)
TIOTROPIUM (2,895)
BUDESONIDE\FORMOTEROL (2,279)
FLUTICASONE\SALMETEROL (1,904)
ADALIMUMAB (1,712)
PREDNISONE (1,237)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145)
MEPOLIZUMAB (1,107)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967)
DUPILUMAB (907)
Which OBINUTUZUMAB Alternatives Have Lower Chronic obstructive pulmonary disease Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE